American Society of Clinical Oncology
Tracked across 25 events · 316 articles · First seen May 06, 2025 · Last active Jun 11, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Tech
The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, held in Chicago from May 29 to June 2, served as a crucial platform for major pharmaceutical and biotechnology companies to present significant advancements in…
Impact: The American Society of Clinical Oncology (ASCO) Annual Meeting is the key venue where the new oncology data from various pharmaceutical companies, including Menarini Group, Jiangsu Hengrui, Kura Oncology, and Akeso, were presented.
May 25, 2026 · 26 articles
Tech
Dassault Systèmes — Medidata Solutions, a Dassault Systèmes brand, presented two pivotal research abstracts at the American Society of Clinical Oncology 2026 Annual Meeting. The research, conducted by the Dassault Systèmes — Medidata Solutions Research…
Impact: The American Society of Clinical Oncology is the host of the 2026 Annual Meeting where Dassault Systèmes — Medidata Solutions presented its research, serving as a key platform for disseminating medical advancements.
May 29, 2026 · 7 articles
Tech
A groundbreaking clinical trial, OPTIMA, led by University College London and coordinated by the University of Warwick, has demonstrated that a genomic test called Prosigna can safely identify breast cancer patients who can avoid chemotherapy.…
Impact: The American Society of Clinical Oncology is hosting its annual meeting where the groundbreaking results of the OPTIMA trial are being presented, disseminating the findings to a global audience of cancer specialists.
May 29, 2026 · 21 articles
Tech
New research presented at the 2026 American Society of Clinical Oncology>>> Annual Meeting indicates that GLP-1 medications, widely used for weight loss and diabetes, may significantly reduce the risk of developing various cancers, including breast…
Impact: The American Society of Clinical Oncology>>> Annual Meeting served as the platform for presenting the significant research findings on GLP-1 receptor agonist and breast cancer prevention.
Jun 02, 2026 · 37 articles
Tech
Impact: The American Society of Clinical Oncology featured the study findings at its annual meeting, with its chief medical officer, Julie Gralow, endorsing the high quality of evidence presented.
Jun 01, 2025 · 7 articles
Tech
Sichuan Kelun-Biotech Biopharmaceutical announced the positive first-in-human study results for its novel B7-H3 ADC SKB500 at the 2026 American Society of Clinical Oncology Annual Meeting in Chicago, United States. Professor Liu Haifeng from Jilin Provincial…
Impact: The American Society of Clinical Oncology hosted the annual meeting where the study results for SKB500 were presented, serving as a key platform for disseminating medical advancements.
Jun 03, 2026 · 6 articles
Tech
Impact: The American Society of Clinical Oncology (ASCO) Annual Meeting served as a platform for IMUNON to present the unprecedented overall survival data from its Phase 2 OVATION 2 Study of IMNN-001, bringing significant attention to the therapy.
May 06, 2025 · 6 articles
Tech
Dassault Systèmes — Medidata Solutions, a Dassault Systèmes brand, unveiled its enhanced AI-powered imaging solution, Dassault Systèmes — Medidata Solutions Imaging, at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting. This solution integrates…
Impact: The American Society of Clinical Oncology (ASCO) hosted the annual meeting where Dassault Systèmes — Medidata Solutions unveiled its new solution, serving as a platform for the announcement and contributing to the dissemination of the technology.
May 28, 2026 · 6 articles
Tech
Moleculin Biotech announced new data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, highlighting the differentiated cardiac safety profile of its lead drug candidate, Annamycin. A pooled analysis across five completed clinical…
Impact: The American Society of Clinical Oncology (ASCO) Annual Meeting served as the platform for Moleculin Biotech to present its positive cardiac safety data for Annamycin.
May 21, 2026 · 7 articles
Tech
Molecular Partners AG announced it will hold trial-in-progress poster presentations on its lead targeted alpha radiotherapy candidate, MP0712, at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and the Society of Nuclear Medicine…
Impact: The American Society of Clinical Oncology (ASCO) is hosting its Annual Meeting where Molecular Partners will present trial-in-progress poster presentations on MP0712.
May 30, 2026 · 8 articles
Tech
Orion announced the first clinical data from its Phase 1/2 TEADES trial for ODM-212, an investigational oral pan-TEAD inhibitor, at the 2026 American Society of Clinical Oncology Annual Meeting. The results indicated that ODM-212 was…
Impact: The American Society of Clinical Oncology Annual Meeting served as the platform for Orion to present its initial clinical data for ODM-212.
May 21, 2026 · 6 articles
Tech
A new study led by NYU Langone Health has shown that a combination therapy of the personalized mRNA vaccine intismeran (manufactured by Moderna>>>) and the immunotherapy drug pembrolizumab (Keytruda, manufactured by Merck & Co.>>>) significantly…
Impact: The American Society of Clinical Oncology>>> is hosting the presentation of the trial results, solidifying its role as a central platform for disseminating significant cancer research. This event enhances its prestige and influence within the oncology community.
Jun 01, 2026 · 6 articles
Tech
Doctors have reported 'unprecedentedly strong responses' to amivantamab, an injection developed by Johnson & Johnson, in a clinical trial for treatment-resistant head and neck cancer. The international study, led by the Institute of Cancer Research,…
Impact: The results of the amivantamab trial are being presented at the annual meeting of the American Society of Clinical Oncology, providing a platform for wider recognition of the breakthrough.
May 30, 2026 · 20 articles
Tech
Fulgent Genetics announced and presented updated interim data from its open-label, randomized Phase 2 study of FID-007 in combination with Cetuximab for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) at the…
Impact: The American Society of Clinical Oncology is hosting the annual meeting where Fulgent Genetics presented its FID-007 data, providing a platform for the dissemination of important clinical research.
May 21, 2026 · 8 articles
Tech
A growing number of Americans are living longer with cancer due to significant advancements in targeted drugs and a deeper understanding of cancer biology. The American Cancer Society>>> reports that 7 out of 10 cancer…
Impact: The meeting of the American Society of Clinical Oncology>>> highlighted significant studies and trial results for new life-extending cancer drugs.
Jun 03, 2026 · 6 articles
Tech
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. announced positive results from its Phase III OptiTROP-Lung05 clinical study for sacituzumab tirumotecan (sac-TMT) in combination with pembrolizumab (KEYTRUDA) as a first-line treatment for non-small cell lung cancer (NSCLC). The…
Impact: The organization hosted the annual meeting where the Phase III clinical study results were presented as an oral presentation, providing a platform for dissemination of the findings.
May 30, 2026 · 14 articles
Tech
Innovent Biologics announced updated long-term follow-up data from its Phase 1 PoC clinical study of IBI363 (PD-1/IL-2 bispecific fusion protein) in advanced immunotherapy-resistant non-small cell lung cancer (NSCLC) at the 2026 American Society of Clinical…
Impact: The American Society of Clinical Oncology (ASCO) Annual Meeting is the platform where the updated clinical data for IBI363 was presented, providing a significant forum for disseminating these important findings to the medical and scientific community.
May 21, 2026 · 9 articles
Tech
Dizal Pharmaceutical announced positive results from two studies in non-small cell lung cancer (NSCLC) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. The first study showcased DZD6008, a fourth-generation EGFR TKI, demonstrating…
Impact: The American Society of Clinical Oncology (ASCO) Annual Meeting served as the platform for Dizal Pharmaceutical to present its clinical trial results, providing a credible forum for dissemination.
May 31, 2026 · 6 articles
Tech
Johnson & Johnson>>>'s prostate cancer drug, Apalutamide>>>, in combination with hormone-blocking therapy, has shown significant success in late-stage clinical trials. The study, presented at the American Society of Clinical Oncology>>> meeting, revealed that the regimen…
Impact: The American Society of Clinical Oncology>>> meeting served as the platform for presenting the groundbreaking trial data for Apalutamide>>>.
May 31, 2026 · 6 articles
Tech
Researchers have reported a significant breakthrough in treating advanced pancreatic cancer with an experimental pill called daraxonrasib, developed by Revolution Medicines. The daily pill nearly doubled the median survival time for patients whose metastatic cancer…
Impact: The American Society of Clinical Oncology meeting in Chicago was the venue where the significant findings of the daraxonrasib study were presented to the medical community.
May 29, 2026 · 74 articles
95
Jiangsu Hengrui presented studies American Society of Clinical OncologyASCO 2026 Oncology Data...
90
Dassault Systèmes — Medidata Solutions presented research abstracts American Society of Clinical OncologyMedidata Presents Oncology...
90
Innovent Biologics presented updated data American Society of Clinical OncologyIBI363 Shows Survival...
90
Dizal Pharmaceutical presented data American Society of Clinical OncologyDizal Presents Positive NSCLC Data
90
Janice Mehnert presented results American Society of Clinical OncologyMelanoma Vaccine Reduces...
90
Elizabeth McDonald (radiologist) presented research findings American Society of Clinical OncologyGLP-1 Drugs Reduce Cancer Risk
90
Kura Oncology highlighted data American Society of Clinical OncologyASCO 2026 Oncology Data...
85
Rob Stein presented findings American Society of Clinical OncologyProsigna Test Reduces...
80
American Society of Clinical Oncology hosted meetingGLP-1 Drugs Reduce Cancer Risk
80
Akeso announced presentations American Society of Clinical OncologyASCO 2026 Oncology Data...
70
American Society of Clinical Oncology will present findingsProsigna Test Reduces...
70
American Society of Clinical Oncology highlighted studyTargeted Cancer Drugs...
70
Jennifer L. Knox presented assessment American Society of Clinical OncologyRevolution_Medicines'...
70
Karyopharm Therapeutics presented data American Society of Clinical OncologyASCO 2026 Oncology Data...
50
American Society of Clinical Oncology presented trial results DaraxonrasibRevolution_Medicines'...
40
American Society of Clinical Oncology selected findings for presentationKelun-Biotech sac-TMT...
NEWSDESK
Track American Society of Clinical Oncology live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard